KYOTO, Japan, Feb. 22, 2016 -- Nidec Corporation (NYSE:NJ) (the “Company”) announced today that Mr. Mutsuo Tahara, a valued outside member of the Company’s Board of Directors, passed away on February 19, 2016.
Mr. Mutsuo Tahara had served on the Company’s Board of Directors since June 2014 and provided the Company with valuable insights based on his rich professional background in law.
We extend our heartfelt condolences to his family and join them in mourning his passing, with deep appreciation for his commitment to effective corporate governance of the Company.
Contact: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 [email protected]


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



